Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs Lumora

Henry Meds
Graded #48

Higher grade

vs+11.2
Lumora
Graded #222

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 66.1/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHenry Meds +36
72
36
Dose & formulationHenry Meds +5
80
75
Clinical oversightLumora +7
80
87
Labs & monitoringHenry Meds +2
78
76
FulfillmentHenry Meds +4
78
74
Contract termsHenry Meds +23
78
55
Henry Meds · left barLumora · right bar

The numbers

MetricHenry MedsLumora
WeighScore77.3/10066.1/100
GradeC+C
Scorecard rank#48#222
Semaglutide$197/mo (injectable; 12-month plan paid upfront in full, $2,364)$199/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$234/mo (compounded oral tablets; 12-month plan paid upfront in full, $2,808)$299/mo (starting dose, compounded)
CoverageMulti-stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Henry Meds

Graded #48 · C+

Strengths

  • Published plan prices identify their upfront-payment requirement
  • Medication, provider access, applicable supplies and shipping included if prescribed
  • Compounded injectable semaglutide and oral options listed

Where it loses points

  • The $197 semaglutide headline requires $2,364 upfront, not monthly payments
  • The listed $234 tirzepatide offer is oral compounded medication, not an injectable quote
  • Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Lumora

Graded #222 · C

Strengths

  • Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
  • Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
  • LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
  • Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
  • Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141

Where it loses points

  • Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
  • Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
  • Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
  • No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
  • Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard